cs.LGNov 15, 2026

Reasoning in the loop: antibody lead optimization by probing mechanism and measurement

Authors: Samuel Stanton, Aaron Solomon, Emily Delaney, Melanie Montgomery, Crystal Humphries, Timothy Acker, Ryan Henrici, Charbel Eid, 

Organizations: Anthropic · BigHat Biosciences

Abstract

Lab-in-the-loop systems, in which a model proposes molecules, automated assays measure their properties and the results retrain the model, are a popular approach to antibody lead optimization. These systems optimize for a specification defined with metrics computed from instrument signals, so their success depends on how well those metrics serve as proxies for the properties a drug candidate needs. When a metric is a poor proxy, neither a better model nor more data will fix it, and identifying the problem usually requires expert review. We report two campaigns run on BigHat Biosciences' Milliner platform, one on an anti-albumin nanobody (VHH) and one on an anti-mesothelin single-chain variable fragment (scFv), in which a research team and a general-purpose AI agent, Claude, brought scientific reasoning into the loop. Over seven rounds and about 1,010 design variants we built libraries from antibody lineage, structure and biophysics, and found from the raw curves that on each scaffold one thermal metric did not measure what its name implied. The libraries were built as controlled comparisons, so the results also show what each mutation contributes to each property. We fit a physical model of the curves, used it to choose metrics suited to each scaffold, and changed the experimental protocol, varying protein concentration and heating rate, to test the model against pre-registered predictions. Both leads improve on their parents in affinity, thermal stability and aggregation while improving or maintaining yield and purity.

Explore similar work

CardsList
  1. Aptamers as a sandbox for lab-in-the-loop agentic molecular discovery

    Oct 17, 2026Zachary Cutts, John Coller, Rachel Chen +9AI Agents for Scientific DiscoveryMolecule Design

  2. Can agents reliably design therapeutic antibodies?

    Oct 31, 2026Asli Alpman, Nick Bhattacharya, Aaron Solomon +1Tool-Using AgentsLLM Agent Reliability

  3. A Comprehensive Benchmark of Computational Models for Antibody--Antigen Binding Affinity

    May 23, 2025Xinyan Zhao, Yi-Ching Tang, Victor J Cantu +7antibody designProtein Design